U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive - CTV News

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive – CTV News

April 24, 2026

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV NewsTrump psychedelics order largely symbolic, analysts say The GuardianIbogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic CNNDonald Trump is giving psychedelic medicines a welcome boost The EconomistFDA fast-tracks review of three psychedelic drugs after Trump order The Independent